New Diagnostic Tools will Revolutionize Rheumatology

Today’s therapeutic practices in rheumatology could one day go the way of the rotary telephone due to advances in imaging, proteomics and other areas.

The next generation of rheumatology patients could be unlike anything we have seen to date. Will DMARDs be a thing of the past? Corticosteroid treatment unnecessary? If disease is diagnosed before onset, traditional treatments could one day be increasingly unnecessary.In this slideshow, we summarize new advances in technology as told by William H. Robinson and Rong Mao in the Oct.  6, 2015 issue of Nature Reviews Rheumatology. New technology, they wrote, will aid in the understanding, diagnosis and treatment of rheumatic diseases in coming years.“The past 10 years have brought us a new raft of technological advances - both incremental and disruptive - that are enabling us to interrogate and manage rheumatic diseases with increasing sophistication,” Robinson and Mao write. 

References:

“Technological advances transforming rheumatology,”Nature Rheumatology Reviews. DOI:10.1038/nrrheum.2015.137  Published online Oct. 6, 2015

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.